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P-gp, MRP2 and BCRP are efflux transporters, members of the family of ATP binding 
cassette (ABC) transporters. These transporters are located on the apical membrane of the 
intestinal epithelium, where they may limit absorption of orally administered drugs. Study 
of drug interactions with/on intestinal efflux transporters is necessary to provide safe and 
effective treatment. The Caco-2 cell line is FDA recommended in vitro model of intestinal 
barrier and it is used for bidirectional testing of substrates and inhibitors of ABC 
transporters in preclinical research. However, this methodology has several shortcomings, 
so the need of introduction of new experimental models is increasing and the ex vivo 
method based on human or rat intestine is a promising option. Precision-cut intestinal 
slices (PCIS) represent a mini-model of the organ and contain all types of cells of the 
tissue. We used both in vitro model using Caco-2 cell monolayers for drug transport study 
and in our lab established ex vivo method of PCIS for accumulation study and 
rhodamine123 (RHD123) as a model substrate of P-gp. We analyzed interactions of 
selected protease inhibitors (saquinavir, atazanavir) and nucleoside reverse transcriptase 
inhibitors (zidovudine, tenofovir disoproxil fumarate) on this efflux transporter with 
subsequent comparison of both methods. Of tested antiretrovirals, saquinavir, and 
atazanavir caused concentration dependent decrease in the efflux ratio and increase in 
ex vivo accumulation of RHD123 in in vitro and ex vivo experiments, respectively. In 
conclusion, we confirmed that saquinavir, and atazanavir might inhibit intestinal P-gp and 
thus increase the absorption of P-gp substrates. Importantly, we demonstrated that rat 
PCIS provide comparable results with those obtained using Caco-2 model. Therefore, rat 
PCIS may represent more physiological alternative to currently preferred in vitro method 
and the establishing of human PCIS would be an additional step closer to real clinical 
environment. 
